Chantal Dreyer Selected Research

Chantal Dreyer Research Topics

Disease

19	Neoplasms (Cancer) 01/2018 - 01/2009
6	Neuroendocrine Tumors (Neuroendocrine Tumor) 09/2012 - 08/2010
5	Hepatocellular Carcinoma (Hepatoma) 04/2014 - 12/2009
2	Carcinoma (Carcinomatosis) 01/2016 - 12/2010
2	Hypertension (High Blood Pressure) 06/2012 - 01/2009
2	Kidney Neoplasms (Kidney Cancer) 02/2012 - 01/2009
2	Carcinogenesis 10/2010 - 08/2010
2	Renal Cell Carcinoma (Grawitz Tumor) 08/2010 - 01/2009
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 09/2016
1	Adenocarcinoma 07/2016
1	Aneuploidy (Aneuploid) 07/2016
1	Chromosomal Instability (Chromosome Stability) 07/2016
1	Necrosis 04/2015
1	Cholangiocarcinoma 04/2015
1	Infections 11/2012
1	Sepsis (Septicemia) 11/2012
1	Septic Shock (Toxic Shock Syndrome) 11/2012
1	Hand-Foot Syndrome 06/2012
1	Diarrhea 06/2012
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2011
1	Carcinoid Tumor (Carcinoid) 12/2010
1	Neuroendocrine Carcinoma 12/2010
1	Neoplasm Metastasis (Metastasis) 12/2010
1	Colorectal Neoplasms (Colorectal Cancer) 10/2010
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 08/2010
1	Disease Progression 01/2009
1	Blister (Bulla) 01/2009
1	Hypothyroidism 01/2009
1	Fatigue 01/2009
1	Asthenia 01/2009

Drug/Important Bio-Agent (IBA)

10	Sunitinib (Sutent)FDA Link 01/2018 - 01/2009
4	Everolimus FDA Link 06/2012 - 08/2010
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 07/2011
3	Gemcitabine FDA Link 09/2016 - 08/2011
3	Sorafenib (BAY 43-9006)FDA Link 04/2014 - 07/2010
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2012 - 12/2010
3	TOR Serine-Threonine KinasesIBA 06/2011 - 08/2010
2	Immune Checkpoint InhibitorsIBA 01/2017 - 03/2016
2	Antineoplastic Agents (Antineoplastics)IBA 11/2012 - 12/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2012 - 12/2010
2	temsirolimus FDA Link 02/2012 - 08/2010
2	Imatinib Mesylate (Gleevec)FDA Link 08/2010 - 01/2009
1	PlatinumIBA 09/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2016
1	DNA (Deoxyribonucleic Acid)IBA 07/2016
1	Proteins (Proteins, Gene)FDA Link 07/2016
1	IntegrinsIBA 07/2016
1	Mitogen-Activated Protein KinasesIBA 03/2016
1	DTS-108IBA 01/2016
1	OligopeptidesIBA 01/2016
1	EsterasesIBA 01/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2016
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2015
1	CoagulaseIBA 11/2012
1	C-Reactive ProteinIBA 11/2012
1	Growth Factor ReceptorsIBA 06/2012
1	Sirolimus (Rapamycin)FDA Link 02/2012
1	ridaforolimusIBA 02/2012
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2012
1	antineoplaston A10 (A 10)IBA 07/2011
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 06/2011
1	Cyclin D1IBA 06/2011
1	MTOR InhibitorsIBA 06/2011
1	Fluorouracil (Carac)FDA LinkGeneric 10/2010
1	Phosphotransferases (Kinase)IBA 08/2010
1	Antihypertensive Agents (Antihypertensives)IBA 01/2009
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2009
1	Tyrosine Kinase InhibitorsIBA 01/2009
1	Thyroid HormonesIBA 01/2009

Therapy/Procedure

10	Therapeutics 09/2016 - 01/2009
7	Drug Therapy (Chemotherapy) 09/2016 - 07/2010
1	Adjuvant Chemotherapy 09/2016
1	Palliative Care (Palliative Therapy) 11/2012
1	Drug Tapering 01/2009